Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC).
Opinion | Clinicians Too Play a Role in Community Violence Intervention
Mercado is a third-year medical student. In 2020, the U.S. experienced a 30% surge in gun-related homicides, with firearm deaths becoming the leading cause of
November 7, 2024